Dianthus Therapeutics, Inc. /DE/

DNTH · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $4.6B · 92 employees
148
SEC Filings
$88.32
Close 2026-10-01
92
Employees

Business Summary

Dianthus Therapeutics is a clinical-stage biotechnology company developing therapies for severe autoimmune diseases. Its lead candidate, claseprubart, is a monoclonal antibody targeting active C1s complement protein, currently in Phase 2/3 trials for generalized Myasthenia Gravis (gMG), CIDP, and MMN. Its second candidate, DNTH212, is a bifunctional fusion protein targeting BDCA2 and BAFF/APRIL for autoimmune diseases including systemic lupus erythematosus.

Latest Stock Quote

DNTH 2026-10-01 $88.32 O:$88.4 H:$91.04 L:$87.22 Vol:0.8M VWAP:$89.0859
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001690585-26-000006EDGAR93K words
2025-03-112024-12-310000950170-25-037131EDGAR90K words
2024-03-212023-12-310000950170-24-034681EDGAR87K words
2023-03-232022-12-310000950170-23-009331EDGAR95K words
2022-03-082021-12-310001193125-22-068759EDGAR99K words
2021-03-032020-12-310001193125-21-066707EDGAR106K words
2020-03-032019-12-310001193125-20-059835EDGAR108K words
2019-03-192018-12-310001193125-19-078948EDGAR107K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-042026-06-300001690585-26-000034EDGAR29K words
2025-11-052025-09-300001193125-25-266920EDGAR28K words
2025-08-072025-06-300000950170-25-105030EDGAR26K words
2025-05-122025-03-310000950170-25-069226EDGAR24K words
2024-11-072024-09-300000950170-24-123285EDGAR34K words
2024-08-082024-06-300000950170-24-093948EDGAR32K words
2024-05-092024-03-310000950170-24-057022EDGAR30K words
2023-11-092023-09-300000950170-23-062070EDGAR34K words
2023-08-032023-06-300000950170-23-037605EDGAR26K words
2023-05-152023-03-310000950170-23-022192EDGAR23K words
2022-11-032022-09-300000950170-22-021603EDGAR62K words
2022-08-042022-06-300001193125-22-211881EDGAR64K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-040001690585-26-000033EDGAR4K words
2026-03-260001690585-26-000010EDGAR11K words
2026-03-120001193125-26-103053EDGAR28K words
2026-03-090001193125-26-097555EDGAR3K words
2026-01-120001193125-26-009898EDGAR10K words
2025-11-050001193125-25-266867EDGAR4K words
2025-11-030001193125-25-262188EDGAR10K words
2025-10-160001193125-25-240858EDGAR2K words
2025-09-110001193125-25-200715EDGAR28K words
2025-09-080001193125-25-197751EDGAR3K words

148 total filings indexed. 118 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

autoimmune-diseases generalized-myasthenia-gravis-(gmg) chronic-inflammatory-demyelinating-polyneuropathy-(cidp) multifocal-motor-neuropathy-(mmn) systemic-lupus-erythematosus-(sle) complement-dependent-diseases yte-half-life-extension-technology subcutaneous-(s.c.)-injection-via-pre-filled-pen

Company Identity

CIK0001690585
TickerDNTH
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.dianthustx.com
Listed2023-09-12

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: da443d439405601ded25630ba402c0f76e1a681134d3212ffbeaba995ed549db
parent: 55c0de812f0616a9863c9911118b81195b4b9c2c0f539b472337ecc179a2463f
content hash: 5d7d9d1e60812e3a6bb2f23d07c41d9198b1f32029274ffe077a060d8fa9dc7e
signed: 2026-10-13T12:01:10.040Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up DNTH using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on DNTH, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/DNTH (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.